Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.62 (
caspase-9
)
7,507
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TP53-regulated inhibitor of apoptosis 1
(
TRIAP1
) is a novel apoptosis inhibitor that binds HSP70 in the cytoplasm and blocks the formation of the apoptosome and
caspase-9
activation.
TRIAP1
has been shown to be upregulated in many types of cancers; however, its role remains elusive. We determined the
TRIAP1
mRNA levels in a panel of human tissues and found its expression to be ubiquitous. Normal breast, as well as non-tumorigenic breast cells, exhibited lower
TRIAP1
mRNA levels than breast cancer cells or their drug-resistant derivatives.
TRIAP1
is a small, evolutionarily conserved protein that is 76 amino acids long. We found that yeast cells, in which the
TRIAP1
homologue was knocked out, had increased sensitivity to doxorubicin. Equally, RNA interference in breast cancer drug-resistant cells demonstrated that downregulation of
TRIAP1
impaired cell growth in the presence of doxorubicin. As expected,
caspase-9
activation was diminished after overexpression of
TRIAP1
in drug-resistant cells. Importantly, stable transfections of a
TRIAP1
expression plasmid in CAL51 cells led to a marked increase in the number of doxorubicin-resistant clones, that was abolished when cells expressed hairpins targeting
TRIAP1
. In addition, we showed that
TRIAP1
expression was also triggered by estrogen deprivation in MCF-7 cells. Although both polyclonal and monoclonal antibodies generated for the present study failed to robustly detect
TRIAP1
, we demonstrated that
TRIAP1
represents a novel marker for drug resistance in breast cancer cells and it may be used in the stratification of breast cancer patients once a suitable antibody has been developed. Equally, these studies open potential drug development strategies for blocking
TRIAP1
activity and avoiding drug resistance.
...
PMID:Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance. 2599 39